ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE, AND PREPARATION METHOD THEREOF
Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for prepa...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Song LI Wenjie XU Yang WANG Yanxin ZHENG Jie YAN Jianqiong ZHI |
description | Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
En esta invención se proporcionan una serie de complejos supermoleculares (compuestos) con doble acción que están compuestos por el compuesto con efecto bloqueante del receptor de angiotensina II (AT1), inhibidor de neprilisina (NEPi) y sus cationes farmacéuticamente aceptables. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2018008531A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2018008531A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2018008531A3</originalsourceid><addsrcrecordid>eNqNi8EKglAQRd20iOofhtYFmgRunzr6BnLm8ZyFO5F4QRAl2P-TRh_Q6sI5566ju-GaRJFbYiACjwU6FQ-G1dTC1Co0qCaXCynOtARGB8SWclq6Qhon7ewOX-k8OuONkvDys1KCWvQo1TZa3YbHFHa_3UT7CrWwxzC--jCNwzU8w7tvulOcZHGcndPEpH9FH9yWNog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE, AND PREPARATION METHOD THEREOF</title><source>esp@cenet</source><creator>Song LI ; Wenjie XU ; Yang WANG ; Yanxin ZHENG ; Jie YAN ; Jianqiong ZHI</creator><creatorcontrib>Song LI ; Wenjie XU ; Yang WANG ; Yanxin ZHENG ; Jie YAN ; Jianqiong ZHI</creatorcontrib><description>Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
En esta invención se proporcionan una serie de complejos supermoleculares (compuestos) con doble acción que están compuestos por el compuesto con efecto bloqueante del receptor de angiotensina II (AT1), inhibidor de neprilisina (NEPi) y sus cationes farmacéuticamente aceptables.</description><language>eng ; spa</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190515&DB=EPODOC&CC=MX&NR=2018008531A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190515&DB=EPODOC&CC=MX&NR=2018008531A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Song LI</creatorcontrib><creatorcontrib>Wenjie XU</creatorcontrib><creatorcontrib>Yang WANG</creatorcontrib><creatorcontrib>Yanxin ZHENG</creatorcontrib><creatorcontrib>Jie YAN</creatorcontrib><creatorcontrib>Jianqiong ZHI</creatorcontrib><title>ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE, AND PREPARATION METHOD THEREOF</title><description>Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
En esta invención se proporcionan una serie de complejos supermoleculares (compuestos) con doble acción que están compuestos por el compuesto con efecto bloqueante del receptor de angiotensina II (AT1), inhibidor de neprilisina (NEPi) y sus cationes farmacéuticamente aceptables.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi8EKglAQRd20iOofhtYFmgRunzr6BnLm8ZyFO5F4QRAl2P-TRh_Q6sI5566ju-GaRJFbYiACjwU6FQ-G1dTC1Co0qCaXCynOtARGB8SWclq6Qhon7ewOX-k8OuONkvDys1KCWvQo1TZa3YbHFHa_3UT7CrWwxzC--jCNwzU8w7tvulOcZHGcndPEpH9FH9yWNog</recordid><startdate>20190515</startdate><enddate>20190515</enddate><creator>Song LI</creator><creator>Wenjie XU</creator><creator>Yang WANG</creator><creator>Yanxin ZHENG</creator><creator>Jie YAN</creator><creator>Jianqiong ZHI</creator><scope>EVB</scope></search><sort><creationdate>20190515</creationdate><title>ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE, AND PREPARATION METHOD THEREOF</title><author>Song LI ; Wenjie XU ; Yang WANG ; Yanxin ZHENG ; Jie YAN ; Jianqiong ZHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2018008531A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2019</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Song LI</creatorcontrib><creatorcontrib>Wenjie XU</creatorcontrib><creatorcontrib>Yang WANG</creatorcontrib><creatorcontrib>Yanxin ZHENG</creatorcontrib><creatorcontrib>Jie YAN</creatorcontrib><creatorcontrib>Jianqiong ZHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Song LI</au><au>Wenjie XU</au><au>Yang WANG</au><au>Yanxin ZHENG</au><au>Jie YAN</au><au>Jianqiong ZHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE, AND PREPARATION METHOD THEREOF</title><date>2019-05-15</date><risdate>2019</risdate><abstract>Provided are a supramolecular composite comprising an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The invention further provides a method for preparing the composite and an application of the composite for preparing a pharmaceutical product for treating heart failure.
En esta invención se proporcionan una serie de complejos supermoleculares (compuestos) con doble acción que están compuestos por el compuesto con efecto bloqueante del receptor de angiotensina II (AT1), inhibidor de neprilisina (NEPi) y sus cationes farmacéuticamente aceptables.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; spa |
recordid | cdi_epo_espacenet_MX2018008531A |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE, AND PREPARATION METHOD THEREOF |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A37%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Song%20LI&rft.date=2019-05-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2018008531A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |